| human | Q5 |
| P6178 | Dimensions author ID | 01010701573.25 |
| 01160365730.16 | ||
| P496 | ORCID iD | 0000-0002-5640-9126 |
| P27 | country of citizenship | Sweden | Q34 |
| P69 | educated at | Lund University Medical Faculty Foundation | Q45136415 |
| P108 | employer | Karolinska Institutet | Q219564 |
| Södersjukhuset | Q1509325 | ||
| Karolinska University Hospital | Q1734280 | ||
| Helsingborgs lasarett | Q2998877 | ||
| P734 | family name | Hall | Q1551523 |
| Hall | Q1551523 | ||
| Hall | Q1551523 | ||
| P735 | given name | Per | Q13582800 |
| Per | Q13582800 | ||
| P106 | occupation | scientist | Q901 |
| P21 | sex or gender | male | Q6581097 |
| Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
| Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
| Q41982570 | 25 years after Chernobyl: lessons for Japan? |
| Q33848895 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy |
| Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
| Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
| Q47956674 | A Biologically Based Model for Liver Cancer Risk in the Swedish Thorotrast Patients |
| Q62583374 | A Combined Segmentation and Registration Framework for Bilateral and Temporal Mammogram Analysis |
| Q37697979 | A clinical model for identifying the short-term risk of breast cancer |
| Q42676622 | A combined analysis of genome-wide association studies in breast cancer |
| Q57250674 | A common coding variant in CASP8 is associated with breast cancer risk |
| Q35957063 | A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density |
| Q48118322 | A comprehensive tool for measuring mammographic density changes over time |
| Q37277137 | A constant risk for familial breast cancer? A population-based family study |
| Q34613513 | A genome-wide association scan on estrogen receptor-negative breast cancer |
| Q29417036 | A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. |
| Q37192589 | A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
| Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
| Q35870483 | A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients |
| Q51562472 | A population-based study of copy number variants and regions of homozygosity in healthy Swedish individuals. |
| Q91960210 | A response to "Personalised medicine and population health: breast and ovarian cancer" |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q58411000 | Acute Myeloid Leukemia Following Hodgkin Lymphoma: A Population-Based Study of 35 511 Patients |
| Q92282046 | Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer |
| Q49416704 | Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density. |
| Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
| Q34655215 | Allergic conditions and brain tumor risk |
| Q40679633 | Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues |
| Q33939753 | An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival |
| Q36073563 | An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression |
| Q37322100 | Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis |
| Q80637356 | Are cancer risks associated with exposures to ionising radiation from internal emitters greater than those in the Japanese A-bomb survivors? |
| Q34374548 | Area and volumetric density estimation in processed full-field digital mammograms for risk assessment of breast cancer |
| Q99232911 | Aspirin and other non-steroidal anti-inflammatory drugs and depression, anxiety, and stress-related disorders following a cancer diagnosis: a nationwide register-based cohort study |
| Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
| Q40198760 | Assessment of Breast Cancer Risk Factors Reveals Subtype Heterogeneity |
| Q97070156 | Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers |
| Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
| Q29547208 | Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q33828680 | Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival |
| Q98780359 | Association between breast cancer risk and disease aggressiveness: characterizing underlying gene expression patterns |
| Q37691149 | Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment |
| Q37292963 | Association of ESR1 gene tagging SNPs with breast cancer risk |
| Q90641407 | Association of Microcalcification Clusters with Short-term Invasive Breast Cancer Risk and Breast Cancer Risk Factors |
| Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
| Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
| Q114182713 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment |
| Q36793535 | Association of infertility and fertility treatment with mammographic density in a large screening-based cohort of women: a cross-sectional study |
| Q52617922 | Association of reproductive history with breast tissue characteristics and receptor status in the normal breast. |
| Q47138002 | Associations between childhood body size and seventeen adverse outcomes: analysis of 65,057 European women |
| Q41080132 | Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q40206782 | Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment |
| Q38914005 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer |
| Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
| Q35494711 | Background risk of breast cancer and the association between physical activity and mammographic density |
| Q36286714 | Background risk of breast cancer influences the association between alcohol consumption and mammographic density |
| Q47176021 | Birth weight and mammographic density among postmenopausal women in Sweden |
| Q45296276 | Birth weight, breast cancer susceptibility loci, and breast cancer risk |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q31147191 | Breaking the matching in nested case-control data offered several advantages for risk estimation |
| Q100457582 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk |
| Q40055436 | Breast Tissue Organisation and its Association with Breast Cancer Risk |
| Q57339169 | Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers |
| Q57339170 | Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers |
| Q46176180 | Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study |
| Q36393099 | Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study |
| Q51696098 | Breast cancer onset in twins and women with bilateral disease. |
| Q36694905 | Breast cancer prognosis in relation to family history of breast and ovarian cancer |
| Q77061002 | Breast cancer risk in women with a primary ovarian cancer--a case-control study |
| Q36393193 | Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q43128186 | Breast cancer screening: time to target women at risk |
| Q35562912 | Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study |
| Q30988479 | Breast cancer tumour growth modelling for studying the association of body size with tumour growth rate and symptomatic detection using case-control data |
| Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
| Q25257428 | CYP17 gene polymorphism in relation to breast cancer risk: a case-control study |
| Q36419325 | CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer |
| Q34793437 | CYP2B6*6 is associated with increased breast cancer risk |
| Q91684233 | CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Prognosis in Patients With Breast Cancer |
| Q46099073 | Cancer as a risk factor for long-term cognitive deficits and dementia |
| Q53391699 | Cancer incidence among Swedish patients exposed to radioactive thorotrast: a forty-year follow-up survey. |
| Q68085044 | Cancer mortality after iodine-131 therapy for hyperthyroidism |
| Q48673956 | Cancer risk after iodine-131 therapy for hyperthyroidism. |
| Q47316764 | Cancer risk after medical exposure to radioactive iodine in benign thyroid diseases: a meta-analysis |
| Q35992813 | Cancer risks in thyroid cancer patients |
| Q28385765 | Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk |
| Q64076881 | Cardiac Structure Doses in Women Irradiated for Breast Cancer in the Past and Their Use in Epidemiological Studies |
| Q88783969 | Cardiac Structure Injury After Radiotherapy for Breast Cancer: Cross-Sectional Study With Individual Patient Data |
| Q35201528 | Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001. |
| Q82600470 | Cardiac doses from Swedish breast cancer radiotherapy since the 1950s |
| Q34640579 | Cause-of-death registers in radiation-contaminated areas of the Russian Federation and Kazakhstan. |
| Q40595247 | Cause-specific mortality in women with breast cancer in situ |
| Q37689779 | Change of mammographic density predicts the risk of contralateral breast cancer--a case-control study |
| Q40497787 | Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients |
| Q61440838 | Childbirth and breast cancer prognosis |
| Q38470389 | Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study |
| Q35558033 | Coffee consumption modifies risk of estrogen-receptor negative breast cancer |
| Q40343406 | Cohort profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA). |
| Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
| Q37368000 | Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms |
| Q42518866 | Comment on "dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors" (Radiat. Environ. Biophys (2012) 51:165-178) by Schöllnberger et al. |
| Q36600605 | Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk |
| Q39231755 | Common diseases as determinants of menopausal age. |
| Q36856357 | Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls |
| Q37177879 | Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival |
| Q52582441 | Common genetic variation and novel loci associated with volumetric mammographic density. |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q33918347 | Common shared genetic variation behind decreased risk of breast cancer in celiac disease |
| Q34792833 | Common variants in ZNF365 are associated with both mammographic density and breast cancer risk |
| Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q28364712 | Comparison of fully and semi-automated area-based methods for measuring mammographic density and predicting breast cancer risk |
| Q38938215 | Comparison of handheld ultrasound and automated breast ultrasound in women recalled after mammography screening |
| Q64065542 | Comparison of self-reported and register-based hospital medical data on comorbidities in women |
| Q30478981 | Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study |
| Q36026731 | Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer |
| Q24607126 | Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes |
| Q34594697 | Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant |
| Q39707352 | Coronary angioplasty and cancer risk: a population-based cohort study in Sweden |
| Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q42502463 | Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study |
| Q24791325 | Correlation test to assess low-level processing of high-density oligonucleotide microarray data |
| Q28388475 | Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations |
| Q37685729 | DNA mismatch repair gene MSH6 implicated in determining age at natural menopause |
| Q47172425 | Decreased birth weight, length, and head circumference in children born by women years after treatment for hyperthyroidism |
| Q34441746 | Defining the role of common variation in the genomic and biological architecture of adult human height |
| Q91884383 | Detection of potential microcalcification clusters using multivendor for-presentation digital mammograms for short-term breast cancer risk estimation |
| Q92282083 | Determinants of Mammographic Density Change |
| Q38446660 | Diagnostic work-up of contralateral breast cancers has not improved over calendar period |
| Q40467185 | Differences in mammographic density between Asian and Caucasian populations: a comparative analysis. |
| Q58546894 | Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer |
| Q61804767 | Discontinuation of adjuvant hormone therapy among breast cancer patients not previously attending mammography screening |
| Q92665806 | Disease trajectories and mortality among women diagnosed with breast cancer |
| Q37205538 | Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm |
| Q92209054 | Does three-dimensional functional infrared imaging improve breast cancer detection based on digital mammography in women with dense breasts? |
| Q36643091 | ESR1 and EGF genetic variation in relation to breast cancer risk and survival |
| Q61875145 | Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk |
| Q89891709 | Effect of a Skin Self-monitoring Smartphone Application on Time to Physician Consultation Among Patients With Possible Melanoma: A Phase 2 Randomized Clinical Trial |
| Q24632163 | Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study |
| Q33889541 | Effects of childhood body size on breast cancer tumour characteristics |
| Q35643266 | Effects of statin use on volumetric mammographic density: results from the KARMA study |
| Q37377626 | Enhancement of mammographic density measures in breast cancer risk prediction |
| Q51962855 | Epidemiology of cancer-related fatigue in the Swedish twin registry. |
| Q24633316 | Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer |
| Q57250672 | Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk |
| Q57202568 | Erratum: Corrigendum: Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk |
| Q34441602 | Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study. |
| Q33262380 | Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968-2002. |
| Q90626355 | European women's perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative study |
| Q99720321 | Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population-based cohort studies and two-sample Mendelian randomization analyses |
| Q34061593 | Evaluation of exome sequencing to estimate tumor burden in plasma |
| Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
| Q53525688 | Exome sequencing of contralateral breast cancer identifies metastatic disease. |
| Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
| Q36588857 | FTO genotype is associated with phenotypic variability of body mass index |
| Q47573086 | Familial concordance in cancer survival: a Swedish population-based study |
| Q92281944 | Family History, Reproductive, and Lifestyle Risk Factors for Fibroadenoma and Breast Cancer |
| Q36611869 | Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study |
| Q40417378 | Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer |
| Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
| Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
| Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
| Q35063160 | Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk |
| Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
| Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q37002930 | Five endometrial cancer risk loci identified through genome-wide association analysis |
| Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
| Q67961242 | Follow the ALARA principle |
| Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
| Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
| Q57420873 | Funding crisis at the Radiation Effects Research Foundation |
| Q36956156 | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer |
| Q24289119 | GWAS of 126,559 individuals identifies genetic variants associated with educational attainment |
| Q42502797 | Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes |
| Q25257621 | Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts |
| Q36164340 | Gene profile and response to treatment |
| Q40137431 | Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium |
| Q37389405 | Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer |
| Q57661758 | Genetic evidence of assortative mating in humans |
| Q57568509 | Genetic implications of bilateral breast cancer: a population based cohort study |
| Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
| Q29417068 | Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study |
| Q54940815 | Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. |
| Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
| Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
| Q51929705 | Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. |
| Q24635370 | Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis |
| Q22305005 | Genetic studies of body mass index yield new insights for obesity biology |
| Q28481918 | Genetic variants in ER cofactor genes and endometrial cancer risk |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q57568320 | Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators |
| Q33889494 | Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer |
| Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
| Q35029543 | Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer |
| Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
| Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
| Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q29417135 | Genome-wide association study identifies a common variant associated with risk of endometrial cancer |
| Q35061252 | Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk |
| Q24645441 | Genome-wide association study identifies novel breast cancer susceptibility loci |
| Q27008356 | Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q28943288 | Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture |
| Q59566871 | Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility |
| Q38823212 | Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk |
| Q80293443 | Genomic instability and prognosis in breast carcinomas |
| Q33901605 | Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development |
| Q96432094 | Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q91521522 | Heritability of Mammographic Breast Density, Density Change, Microcalcifications, and Masses |
| Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
| Q40798325 | Heterogeneity of chemosensitivity of metastatic cutaneous melanoma |
| Q36924460 | High-throughput mammographic-density measurement: a tool for risk prediction of breast cancer |
| Q98732654 | Hormonal determinants of mammographic density and density change |
| Q33248484 | Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study |
| Q37062218 | How to treat male breast cancer |
| Q24630979 | Hundreds of variants clustered in genomic loci and biological pathways affect human height |
| Q38452332 | Hyperthyroidism and suicide: a retrospective cohort study in Sweden |
| Q98664105 | Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors |
| Q34543971 | I'm so tired: biological and genetic mechanisms of cancer-related fatigue |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q37006170 | Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. |
| Q99210133 | Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening |
| Q36720814 | Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk |
| Q36062033 | Identification of a novel percent mammographic density locus at 12q24. |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
| Q57170142 | Identification of nine new susceptibility loci for endometrial cancer |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q35848934 | Identification of two novel mammographic density loci at 6Q25.1. |
| Q92001842 | Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ |
| Q97878698 | Impairment of endoxifen formation in tamoxifen-treated premenopausal breast cancer patients carrying reduced-function CYP2D6 alleles |
| Q35808244 | In Search for the Genetic Basis of Quality of Life in Healthy Swedish Women--A GWAS Study Using the iCOGS Custom Genotyping Array |
| Q57199802 | Incidence and Prognosis of Synchronous and Metachronous Bilateral Breast Cancer |
| Q44443908 | Incidence and survival of Swedish patients with differentiated thyroid cancer |
| Q50554120 | Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. |
| Q73581970 | Incidence of primary malignancies other than breast cancer among women treated with radiation therapy for benign breast disease |
| Q44785219 | Incidence trends of adult primary intracerebral tumors in four Nordic countries |
| Q92710567 | Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer |
| Q92281992 | Inclusion of Plasma Prolactin Levels in Current Risk Prediction Models of Premenopausal and Postmenopausal Breast Cancer |
| Q37614763 | Incorporating genomics into breast and prostate cancer screening: assessing the implications |
| Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
| Q39419020 | Increased pancreatic cancer risk following radiotherapy for testicular cancer |
| Q71783512 | Increased risk of second primary malignancies in patients with gynecological cancer. A Swedish record-linkage study |
| Q35677701 | Increased stomach cancer risk following radiotherapy for testicular cancer |
| Q40721030 | Infection-related hospitalizations in breast cancer patients: Risk and impact on prognosis |
| Q35069831 | Influence of lifestyle factors on mammographic density in postmenopausal women |
| Q46082837 | Influence of radiotherapy for the first tumor on aggressiveness of contralateral breast cancer |
| Q57199805 | Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer |
| Q48181769 | Inherited factors contribute to an inverse association between preeclampsia and breast cancer |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q37225694 | Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk |
| Q90883907 | Interval breast cancer is associated with other types of tumors |
| Q77345776 | Intrauterine exposure to diagnostic X rays and risk of childhood leukemia subtypes |
| Q35605761 | Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients |
| Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
| Q59850156 | Investigation of rare variation in one thousand cancer genes and its association with risk of breast and prostate cancer |
| Q46037843 | Ionising radiation in infancy and adult cognitive function: Authors' reply. |
| Q48549476 | Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design. |
| Q35906350 | Is breast cancer prognosis inherited? |
| Q33455626 | Is genetic background important in lung cancer survival? |
| Q60594500 | Ischemic Heart Disease after Breast Cancer Radiotherapy |
| Q64279327 | Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk |
| Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
| Q61307207 | LBA12_PRPERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): Cost effectiveness analysis results |
| Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
| Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q34158058 | Large-scale genotyping identifies a new locus at 22q13.2 associated with female breast size |
| Q41457193 | Late consequences of radioiodine for diagnosis and therapy in Sweden |
| Q37200404 | Learning a novel technique to identify possible melanomas: are Australian general practitioners better than their U.K. colleagues? |
| Q78009592 | Lenticular opacities in individuals exposed to ionizing radiation in infancy |
| Q33969702 | Leukaemia incidence after iodine-131 exposure |
| Q38464538 | Leukemia following breast cancer: an international population-based study of 376,825 women |
| Q34472074 | Library preparation and multiplex capture for massive parallel sequencing applications made efficient and easy |
| Q33242074 | Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk |
| Q61445357 | Localized mammographic density is associated with interval cancer and large breast cancer: a nested case-control study |
| Q58410899 | Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma |
| Q35535907 | Long-term cognitive impairment in older adult twins discordant for gynecologic cancer treatment |
| Q58793458 | Long-term exposure to insulin and volumetric mammographic density: observational and genetic associations in the Karma study |
| Q34555690 | Long-term mobile phone use and brain tumor risk |
| Q54730200 | Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening. |
| Q40586607 | Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer |
| Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
| Q67894283 | Low risk of cancer after treatment of hyperthyroidism with iodine-131 |
| Q74444419 | Lung cancer risks in women with previous breast cancer |
| Q91824346 | Mammographic Density Change and Risk of Breast Cancer |
| Q51843302 | Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach. |
| Q36043843 | Mammographic breast density and breast cancer: evidence of a shared genetic basis |
| Q36075284 | Mammographic density and molecular subtypes of breast cancer |
| Q33739464 | Mammographic density and survival in interval breast cancers |
| Q100384945 | Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years |
| Q96614431 | Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden |
| Q36057738 | Mammographic density phenotypes and risk of breast cancer: a meta-analysis |
| Q36916765 | Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer |
| Q99720317 | Mammography features for early markers of aggressive breast cancer subtypes and tumor characteristics - a population-based cohort study |
| Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
| Q98772941 | Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer |
| Q34480625 | Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study |
| Q37038646 | Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study |
| Q34248904 | Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways |
| Q36333368 | Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
| Q34551752 | Mobile phone use and the risk of acoustic neuroma |
| Q40597509 | Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 Subtypes |
| Q58411391 | Mortality after cerebral angiography with or without radioactive Thorotrast: an international cohort of 3,143 two-year survivors. |
| Q52909556 | Mortality after long-term exposure to radioactive Thorotrast: a forty-year follow-up survey in Sweden. |
| Q34464074 | Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women |
| Q51056809 | Mortality in patients treated for hyperthyroidism with iodine-131. |
| Q40724665 | Mortality in the offspring of individuals living along the radioactively contaminated Techa River: a descriptive analysis |
| Q33628755 | Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility |
| Q81107957 | Multiple births and breast cancer prognosis: a population based study |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q36965021 | Neonatal growth and breast cancer risk in adulthood |
| Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q36393107 | No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density |
| Q37308596 | No evidence that GATA3 rs570613 SNP modifies breast cancer risk |
| Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
| Q72036040 | Non-Hodgkin's lymphoma and skin malignancies--shared etiology? |
| Q48106959 | Non-participant characteristics and the association between socioeconomic factors and brain tumour risk |
| Q38463130 | Noncancer causes of death in survivors of testicular cancer |
| Q33642714 | NordicDB: a Nordic pool and portal for genome-wide control data |
| Q35752042 | Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures |
| Q37316377 | Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study |
| Q35747294 | Novel measurements of mammary stem cells in human umbilical cord blood as prospective predictors of breast cancer susceptibility in later life |
| Q37222610 | Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy? |
| Q98157907 | Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK |
| Q73603385 | Overestimated risk of second primary malignancies in ovarian cancer patients |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
| Q34250016 | Pancreatic cancer risk after treatment of Hodgkin lymphoma |
| Q80932281 | Parathyroid adenoma and primary CNS tumors |
| Q34289136 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche |
| Q34314861 | Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models |
| Q33889163 | Pathological confirmation of primary lung cancer following breast cancer |
| Q112572520 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes |
| Q37307937 | Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium |
| Q57579827 | Pattern of declining hemoglobin concentration before cancer diagnosis |
| Q40271968 | Pectoral muscle attenuation as a marker for breast cancer risk in full-field digital mammography |
| Q96577047 | Personalized early detection and prevention of breast cancer: ENVISION consensus statement |
| Q57162833 | Physical activity and mammographic density in an Asian multi-ethnic cohort |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
| Q57306202 | Polymorphisms in oxidative stress-related genes and mortality in breast cancer patients – Potential differential effects by radiotherapy? |
| Q84598242 | Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk |
| Q37691217 | Possible influence of mammographic density on local and locoregional recurrence of breast cancer |
| Q57420874 | Potential funding crisis for the Radiation Effects Research Foundation |
| Q92055460 | Prediction and clinical utility of a contralateral breast cancer risk model |
| Q37487782 | Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q91832507 | Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts |
| Q40879609 | Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer |
| Q99572904 | Predictors of Mammographic Microcalcifications |
| Q37306584 | Prenatal ultrasound examinations and risk of childhood leukaemia: case-control study |
| Q47238239 | Preoperative psychological reactions and quality of life among women with an increased risk of breast cancer who are considering a prophylactic mastectomy |
| Q62583372 | Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort |
| Q98183940 | Profiles of histidine-rich glycoprotein associate with age and risk of all-cause mortality |
| Q38477186 | Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden |
| Q35018327 | Progesterone receptor gene variants and risk of endometrial cancer |
| Q43657808 | Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer |
| Q38419595 | Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer. |
| Q35313220 | Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer |
| Q47164954 | Protocol for the melatools skin self-monitoring trial: a phase II randomised controlled trial of an intervention for primary care patients at higher risk of melanoma |
| Q41728154 | Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q96816951 | Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q36009422 | RAD51B in Familial Breast Cancer |
| Q57697485 | RESPONSE: Re: Cancer as a Risk Factor for Long-Term Cognitive Deficits and Dementia |
| Q37318317 | Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer |
| Q44232349 | Radiation-associated thyroid cancer--facts and fiction |
| Q37278975 | Radiation-associated urinary bladder cancer |
| Q70508143 | Radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease |
| Q57697476 | Re: Cancer as a Risk Factor for Dementia: A House Built on Shifting Sand |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q61345345 | Reply to P.A. Leppäluoto |
| Q48888372 | Reproductive factors and risk of meningioma and glioma. |
| Q45951126 | Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. |
| Q61345473 | Response: Re: Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk |
| Q57199817 | Risk Factors for Hormone Receptor-Defined Breast Cancer in Postmenopausal Women |
| Q40087184 | Risk and predictors of psoriasis in patients with breast cancer: a Swedish population-based cohort study |
| Q41488290 | Risk factors and tumor characteristics of interval cancers by mammographic density |
| Q58411595 | Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer |
| Q48474401 | Risk of brain tumors associated with exposure to exogenous female sex hormones. |
| Q34624703 | Risk of childhood leukaemia in the vicinity of nuclear installations--findings and recent controversies. |
| Q42923398 | Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma |
| Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
| Q40554954 | Risk of hospitalisation and death due to bone fractures after breast cancer: a registry-based cohort study |
| Q43615460 | Risk of ischemic heart disease in women after radiotherapy for breast cancer |
| Q77939269 | Risk of leukemia after platinum-based chemotherapy for ovarian cancer |
| Q33665161 | Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patients |
| Q38487369 | Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study |
| Q58410869 | Risk of second non-hematological malignancies among 376,825 breast cancer survivors |
| Q36408560 | Risk of treatment-related esophageal cancer among breast cancer survivors |
| Q36545934 | SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival |
| Q58410884 | Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk |
| Q58411051 | Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors |
| Q37334268 | Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix |
| Q68635962 | Second primary tumors following thyroid cancer. A Swedish record-linkage study |
| Q38471896 | Sex of first child and breast cancer survival: a population-based study |
| Q34765317 | Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q83453976 | Simplifying the TNM system for clinical use in differentiated thyroid cancer |
| Q52957260 | Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast. |
| Q39001880 | Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects |
| Q37165088 | Stomach cancer risk after treatment for hodgkin lymphoma |
| Q89847896 | Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast Cancer |
| Q74111420 | Studies on the Techa river offspring cohort: health effects |
| Q53248788 | Suicide after breast cancer: an international population-based study of 723,810 women. |
| Q38452779 | Survival of male breast cancer patients: population-based cohort study |
| Q21091062 | Swedish population substructure revealed by genome-wide single nucleotide polymorphism data |
| Q28393679 | Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks |
| Q33566957 | TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer |
| Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q40143018 | The HLA-DQβ1 insertion is a strong achalasia risk factor and displays a geospatial north-south gradient among Europeans |
| Q34673513 | The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study |
| Q35781316 | The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients |
| Q36917100 | The UGT1A6_19_GG genotype is a breast cancer risk factor |
| Q90681357 | The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI |
| Q47396853 | The cost-effectiveness of primary care referral to a UK commercial weight loss programme |
| Q34178564 | The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer |
| Q33666335 | The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes |
| Q35078459 | The genetic basis of quality of life in healthy Swedish women: a candidate gene approach |
| Q93054131 | The genetic interplay between body mass index, breast size and breast cancer risk: a Mendelian randomization analysis |
| Q21135294 | The genetic structure of the Swedish population |
| Q92166680 | The impact of alcohol consumption and physical activity on breast cancer: The role of breast cancer risk |
| Q41245224 | The impact of co-morbidity on health-related quality of life in breast cancer survivors and controls |
| Q57568288 | The influence of mammographic density on breast tumor characteristics |
| Q37438166 | The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients |
| Q37131374 | The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer |
| Q57265642 | The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant |
| Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
| Q57568358 | The role of mammography screening attendance and detection mode in predicting breast cancer survival-Is there added prognostic value? |
| Q34151528 | Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies |
| Q70814657 | Thyroid cancer after diagnostic administration of iodine-131 |
| Q47779590 | Thyroid cancer risk after thyroid examination with 131I: a population-based cohort study in Sweden |
| Q71861296 | Thyroid nodularity after diagnostic administration of iodine-131 |
| Q40546472 | Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study |
| Q40470262 | Time-dependent risk of depression, anxiety, and stress-related disorders in patients with invasive and in situ breast cancer. |
| Q37632189 | Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics |
| Q57113132 | Towards Prevention of Breast Cancer: What Are the Clinical Challenges? |
| Q34867822 | Transcriptional consequences of genomic structural aberrations in breast cancer |
| Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
| Q89415928 | Transient bottom water oxygenation creates a niche for cable bacteria in long-term anoxic sediments of the Eastern Gotland Basin |
| Q38830188 | Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients |
| Q58411442 | Treatment-Associated Leukemia Following Testicular Cancer |
| Q68211502 | Tumors after radiotherapy for thyroid cancer. A case-control study within a cohort of thyroid cancer patients |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q90119149 | Uncovering diversity and metabolic spectrum of animals in dead zone sediments |
| Q38105492 | Using patient-reported measurement to pave the path towards personalized medicine |
| Q43627221 | Validation of smoking history in cancer patients |
| Q42692136 | Volumetric mammographic density: heritability and association with breast cancer susceptibility loci |
| Q92216468 | Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study |
| Q40638271 | Worse quality of life in young and recently diagnosed breast cancer survivors compared with female survivors of other cancers: A cross-sectional study |
| Q80126104 | [After the Chernobyl accident: no basis for increased cancer risk in Sweden] |
| Q53592979 | [Increased number of cancer cases following computer tomography in children. Radiation dosage--and cancer risk--can be reduced]. |
| Q95482906 | [Mammography, ultrasound and needle biopsy is the base for diagnostic imaging] |
| Q70552569 | [No reasons to change iodine-131 treatment] |
| Q38439208 | p53 Mutation analysis in breast tumors by a DNA microarray method |
| Q74079753 | p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancer |
| Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
Search more.